Followers | 224 |
Posts | 13430 |
Boards Moderated | 0 |
Alias Born | 03/15/2013 |

Monday, March 13, 2023 6:57:16 PM
Recent ACAD News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2025 08:06:24 PM
- U.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of Acadia in NUPLAZID® (pimavanserin) Composition of Matter Patent • Business Wire • 06/09/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2025 10:01:14 PM
- Acadia Pharmaceuticals to Host R&D Day in New York City on June 25, 2025 • Business Wire • 06/05/2025 01:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2025 08:35:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 10:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 10:05:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 10:05:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 10:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 10:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 10:05:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 08:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2025 08:06:35 PM
- Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference • Business Wire • 05/29/2025 08:05:00 PM
- Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise • Business Wire • 05/27/2025 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/20/2025 08:05:00 PM
- Delaware District Court Rules in Favor of Acadia in NUPLAZID® (pimavanserin) Formulation Patent Litigation • Business Wire • 05/16/2025 05:43:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/09/2025 08:06:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 08:13:19 PM
- Acadia Pharmaceuticals Reports First Quarter 2025 Financial Results and Operating Overview • Business Wire • 05/07/2025 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the BofA Securities 2025 Health Care Conference • Business Wire • 05/05/2025 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2025 11:59:08 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/25/2025 08:54:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/25/2025 08:49:09 PM
- Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2025 • Business Wire • 04/23/2025 08:05:00 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM